Agios Pharma (AGIO) Misses Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts AGIO Hot Sheet
Join SI Premium – FREE
Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.74), $0.07 worse than the analyst estimate of ($1.67).
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
- Mannatech (MTEX) Tops Q2 EPS by 53c
- Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
